Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) Study
Many surgeons have adopted fully endoscopic over microscopic transsphenoidal surgery for nonfunctioning pituitary tumors, although no high-quality evidence demonstrates superior patient outcomes with endoscopic surgery. The goal of this analysis was to compare these techniques in a prospective multicenter controlled study.
Extent of tumor resection was compared after endoscopic or microscopic transsphenoidal surgery in adults with nonfunctioning adenomas. The primary end point was gross-total tumor resection determined by postoperative MRI. Secondary end points included volumetric extent of tumor resection, pituitary hormone outcomes, and standard quality measures.
Seven pituitary centers and 15 surgeons participated in the study. Of the 530 patients screened, 260 were enrolled (82 who underwent microscopic procedures, 177 who underwent endoscopic procedures, and 1 who cancelled surgery) between February 2015 and June 2017. Surgeons who used the microscopic technique were more experienced than the surgeons who used the endoscopic technique in terms of years in practice and number of transsphenoidal surgeries performed (p < 0.001). Gross-total resection was achieved in 80.0% (60/75) of microscopic surgery patients and 83.7% (139/166) of endoscopic surgery patients (p = 0.47, OR 0.8, 95% CI 0.4–1.6). Volumetric extent of resection, length of stay, surgery-related deaths, and unplanned readmission rates were similar between groups (p > 0.2). New hormone deficiency was present at 6 months in 28.4% (19/67) of the microscopic surgery patients and 9.7% (14/145) of the endoscopic surgery patients (p < 0.001, OR 3.7, 95% CI 1.7–7.7). Microscopic surgery cases were significantly shorter in duration than endoscopic surgery cases (p < 0.001).
Experienced surgeons who performed microscopic surgery and less experienced surgeons who performed endoscopic surgery achieved similar extents of tumor resection and quality outcomes in patients with nonfunctioning pituitary adenomas. The endoscopic technique may be associated with lower rates of postoperative pituitary gland dysfunction. This study generally supports the transition to endoscopic pituitary surgery when the procedure is performed by proficient surgeons, although both techniques yield overall acceptable surgical outcomes.
■ CLASSIFICATION OF EVIDENCE Type of question: therapeutic; study design: prospective cohort trial; evidence: class III.
Correspondence Andrew S. Little: c/o Neuroscience Publications, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ. firstname.lastname@example.org.INCLUDE WHEN CITING Published online March 22, 2019; DOI: 10.3171/2018.11.JNS181238.Disclosures Dr. Little is a stockholder in Kogent Surgical, LLC, and has stock options in SPIWay, LLC. Dr. Kelly receives royalties from Mizuho America Inc. Dr. Chicoine has received unrestricted grant funding from IMRIS Inc. Dr. Barkhoudarian has received consulting fees from Vascular Technology Inc. Dr. Gardner is a stockholder in SPIWay, LLC. Dr. Prevedello is a consultant for Stryker Corp., Medtronic, plc, and Codman Neuro, and he receives royalties from KLS Martin, LP.
AsemotaAO, IshiiM, BremH, GalliaGL: Comparison of complications, trends, and costs in endoscopic vs microscopic pituitary surgery: analysis from a US health claims database. 81:458–472, 20172885945310.1093/neuros/nyx350)| false
BarkerFGIIKlibanskiASwearingenB: Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab88:4709–47192003
BarkerFGII, KlibanskiA, SwearingenB: Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. 88:4709–4719, 20031455744510.1210/jc.2003-030461)| false
CiricI, RaginA, BaumgartnerC, PierceD: Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. 40:225–237, 1997900785410.1097/00006123-199702000-00001)| false
DehdashtiARGannaAKarabatsouKGentiliF: Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery62:1006–10172008
DehdashtiAR, GannaA, KarabatsouK, GentiliF: Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. 62:1006–1017, 200810.1227/01.neu.0000325862.83961.1218580798)| false
D’HaensJVan RompaeyKStadnikTHaentjensPPoppeKVelkeniersB: Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. Surg Neurol72:336–3402009
D’HaensJ, Van RompaeyK, StadnikT, HaentjensP, PoppeK, VelkeniersB: Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. 72:336–340, 20091960455110.1016/j.surneu.2009.04.012)| false
ElhadiAM, HardestyDA, ZaidiHA, KalaniMY, NakajiP, WhiteWL, : Evaluation of surgical freedom for microscopic and endoscopic transsphenoidal approaches to the sella. 11 (Suppl 2):69–79, 201525603103)| false
GondimJAAlmeidaJPde AlbuquerqueLAGomesESchopsMFerrazT: Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus29(4):E72010
GondimJA, AlmeidaJP, de AlbuquerqueLA, GomesE, SchopsM, FerrazT: Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. 29(4):E7, 201010.3171/2010.7.FOCUS10167)| false
KnospE, SteinerE, KitzK, MatulaC: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. 33:610–618, 19938232800)| false
MortiniP: Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas. 47:415–420, 201410.1007/s12020-014-0365-025081297)| false
PaluzziA, Fernandez-MirandaJC, StefkoST, ChallinorS, SnydermanCH, GardnerPA: Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. 17:307–319, 20142390757010.1007/s11102-013-0502-4)| false
PatelSK, HusainQ, EloyJA, CouldwellWT, LiuJK: NormanDott, GerardGuiot, and JulesHardy: key players in the resurrection and preservation of transsphenoidal surgery. 33(2):E6, 201210.3171/2012.6.FOCUS1212522853837)| false
ZaidiHAAwadAWBohlMAChappleKKnechtLJahnkeH: Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma. J Neurosurg124:596–6042016
ZaidiHA, AwadAW, BohlMA, ChappleK, KnechtL, JahnkeH, : Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma. 124:596–604, 201610.3171/2015.4.JNS15102)| false
ZhuMYangJWangYCaoWZhuYQiuL: [Endoscopic transsphenoidal surgery versus microsurgery for the resection of pituitary adenomas: a systematic review.]Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi49:236–2392014(Chinese)